GRAPHITE BIO, INC. Shares of Common Stock (par value $0.00001 per share) Controlled Equity OfferingSM Sales AgreementGraphite Bio, Inc. • July 21st, 2022 • Biological products, (no disgnostic substances) • New York
Graphite Bio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
